c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia

Tyrosine kinase inhibitor (TKI) therapy for human cancers is not curative, with relapse due to the continuing presence of tumor cells, referred to as minimal residual disease (MRD) cells. MRD stem or progenitor cells survival in the absence of oncogenic kinase signaling, a phenomenon referred to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesarwani, Meenu, Kincaid, Zachary, Gomaa, Ahmed, Huber, Erika, Rohrabaugh, Sara, Siddiqui, Zain, Bouso, Muhammad F., Latif, Tahir, Xu, Ming, Komurov, Kakajan, Mulloy, James C., Cancelas, Jose A., Grimes, H. Leighton, Azam, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424814/
https://www.ncbi.nlm.nih.gov/pubmed/28319094
http://dx.doi.org/10.1038/nm.4310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424814/
https://www.ncbi.nlm.nih.gov/pubmed/28319094
http://dx.doi.org/10.1038/nm.4310

Ejemplares similares